Adaptive Optics Scanning Laser Ophthalmoscope (Mona IV)
Robotrak Technologies Co., Ltd. · Decision date Oct 27, 2026
What did the FDA decide?
FDA records K261740 as a 510(k) premarket notification, with a decision dated Oct 27, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Ophthalmic
- Decision date
- Oct 27, 2026
Regulatory record facts
- Identifier
- K261740
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Robotrak Technologies Co., Ltd.
- Product code
- MYC
- Decision code
- SESE
- Decision date
- Oct 27, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Ophthalmoscope, Laser, Scanning.
- Applicant
- Robotrak Technologies Co., Ltd.
- Product code
- MYC
- FDA device class
- 2
FDA decision timeline
K261740 received
Application receipt date recorded by FDA.
K261740 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code MYC
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
KOWA FM-600K261255 | Kowa Company, Ltd. Chofu Factory | 510(k) clearance | Sep 11, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Robotrak Technologies Co., Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Nanjing
Sources and methodology
- Original FDA record: K261740
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records